Skip to content

好药价

US · GDRX #3178 按市值排名 上市于 2020
3.36 -0.15 -4.14%
实时 - 追踪5344个代码 - 心跳于87秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 机构持股总比例下降了2.3个百分点。

机构持股

机构持股比例
45.48% -2.34pp
机构数量
181
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

VC/PE Fund16.93%
Private Company13.53%
Mutual Fund10.59%
Individual/Insider3.94%
Hedge Fund3.54%
Public Company0.46%
Government Pension Fund0.35%
Other50.58%

主要股东 截至 2026-08-21

Francisco Partners Management, L.P. 15.41% · 52.58M 股
Idea Men, LLC 12.65% · 43.16M 股
Douglas Hirsch 1.59% · 5.43M 股
Trevor Bezdek 1.59% · 5.43M 股
LSV Asset Management 1.51% · 5.16M 股
Columbia Management Investment Advisers, LLC 1.39% · 4.75M 股
Vanguard Capital Management, LLC 1.37% · 4.67M 股
Silver Lake Technology Management, L.L.C. 1.04% · 3.53M 股
Renaissance Technologies Corp. 0.95% · 3.25M 股
Vanguard Portfolio Management, LLC 0.94% · 3.21M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 28次买入 · 16次卖出

姓名职务持股比例
Francisco Partners Management, L.P. -- 15.41%
Idea Men, LLC -- 12.65%
Douglas Hirsch Co-founder, Chief Mission Officer & Director 1.59%
Trevor Bezdek Co-founder & Chairman 1.59%
Wendy Barnes Chief Executive Officer 0.22%
Agnes Rey-Giraud Independent Director 0.17%
Raj Beri Chief Operating Officer 0.10%
Scott Wagner Interim Chief Executive Officer 0.08%
Christopher McGinnis Chief Financial Officer 0.06%
Romin Nabiey Chief Accounting Officer & Principal Accounting Officer 0.06%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-14 Justin Fengler Senior Vice President of Corporate Strategy & Business Operations Derivative Exercise and Sale -1,354 $3.56
2026-09-14 Justin Fengler Senior Vice President of Corporate Strategy & Business Operations Derivative Exercise and Retained +1,733 --
2026-09-14 Thomas Chan Chief Accounting Officer Derivative Exercise and Sale -1,069 $3.56
2026-09-14 Thomas Chan Chief Accounting Officer Derivative Exercise and Retained +1,032 --
2026-08-25 Francisco Partners Management, L.P. -- Open Market Disposition -1,567,044 $3.44–3.51
2026-08-20 Francisco Partners Management, L.P. -- Derivative Exercise and Sale -5,932,956 $3.50–3.53
2026-08-18 Francisco Partners Management, L.P. -- Derivative Exercise and Retained +1,567,044 --
2026-08-14 Justin Fengler Senior Vice President of Corporate Strategy & Business Operations Derivative Exercise and Sale -21,407 $3.73
2026-08-14 Justin Fengler Senior Vice President of Corporate Strategy & Business Operations Derivative Exercise and Retained +27,125 --
2026-08-14 Thomas Chan Chief Accounting Officer Derivative Exercise and Sale -5,149 $3.73
2026-08-14 Thomas Chan Chief Accounting Officer Derivative Exercise and Retained +4,966 --
2026-08-09 Justin Fengler Senior Vice President of Corporate Strategy & Business Operations Other Derivative Acquisition +190,204 --
2026-08-05 Justin Fengler Senior Vice President of Corporate Strategy & Business Operations Initial Statement of Beneficial 0 --
2026-07-14 Wendy Barnes Chief Executive Officer Derivative Exercise and Sale -120,456 $3.01
2026-07-14 Wendy Barnes Chief Executive Officer Derivative Exercise and Retained +156,832 --
2026-07-14 Christopher McGinnis Chief Financial Officer Derivative Exercise and Sale -16,294 $3.01
2026-07-14 Christopher McGinnis Chief Financial Officer Derivative Exercise and Retained +20,694 --
2026-07-14 Thomas Chan Chief Accounting Officer Derivative Exercise and Sale -2,947 $3.01
2026-07-14 Thomas Chan Chief Accounting Officer Derivative Exercise and Retained +2,845 --
2026-06-15 Agnes Rey-Giraud Independent Director Other Acquisition +73,434 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

好药价 讨论区 0 条评论

发表评论